Loading…
← CockpitCompetitor Analysis › CANHLIFE.NS Canara HSBC Life Insurance CompanyOpen in the cockpit ↗

Canara HSBC Life Insurance CompanyCANHLIFE.NSCompetitor analysis, valuation and peers

India · INR·Financials›Life/Health Insurance

Life insurance joint venture between Canara Bank, HSBC and Punjab National Bank, sold mainly through bank branches.

Momentum weak 29
Mkt cap
$1.29B
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$1.02M
20-day average traded
P/B
7.36×
price to book
ROE
8.2%
delivered
Implied ROE
50.5%
what the price asks
Next earnings
105 days
3 Mar 2027
Close · INR₹127.01
1D-2.3%
1W+3.6%
1M-0.9%
3M-14.9%
6M-7.8%
YTD-14.3%
1Y+4.6%
ATR %4.3%
Beta0.39
52w lowhigh23.8% off high

What Canara HSBC Life Insurance does

Life insurance joint venture between Canara Bank, HSBC and Punjab National Bank, sold mainly through bank branches.

Earns by collecting premiums and investing them, with most policies sold to customers of its parent banks' branches, so growth depends on how many branch staff sell its products and on the volume of savings-linked plans. Canara Bank is the majority shareholder, with HSBC and Punjab National Bank as the other main partners.

Products and services

  • Traditional life insurance plans
  • ULIPs (unit-linked plans)
  • Term/protection insurance

Customers

  • Bank customers of Canara Bank/PNB
  • Retail life insurance buyers

Where it sits in the supply chain

  • Financial services/insurance
  • Life insurance
  • Bancassurance-distributed life…

What could go right

  • Rising life insurance penetration in India
  • Bank branch cross-sell growth

What could go wrong

  • Bancassurance channel concentration risk
  • Interest rate sensitivity of traditional products

Moat: narrow (distribution, brand). Bancassurance access through Canara Bank and PNB's large branch networks drives distribution reach.

Headquarters: Gurugram, India · Founded: 2007

Named competitors

Canara HSBC Life Insurance at a glance

Size Canara HSBC Life Insurance (CANHLIFE.NS) is an India Financials company (Life/Health Insurance) with a market value of $1.29B, the 525th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹127.01 on 18 Nov 2026.

Performance Over six months the shares fell 7.8%, against +0.7% for the median peer and +3.8% for the India market (cap-weighted) — 6th lowest of 15 in its peer set.

Growth Revenue grew 17.1% over the last twelve months (peer median +19.8%); the operating margin is 1.5% (peer median 6.8%).

Valuation It trades at 7.36× book value against a peer median of 0.95× (most expensive of 15).

Price implies The share price implies a return on equity of about 50.5%; Canara HSBC Life Insurance delivers 8.2%, so the price asks more than the business earns today.

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 100CANHLIFE.NS 92
Six months, rebased to 100: Canara HSBC Life Insurance against the median of its 14 peers (local-currency closes).

Canara HSBC Life Insurance financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹142B₹131B₹112B₹95.7B₹90.2B
Revenue growth—+17%+17%+6%—
Net income₹1.34B₹1.27B₹1.17B₹1.13B₹912M
Free cash flown/a₹35.2B₹12.0B₹22.8B₹38.6B
Capital expendituren/a₹104M₹116M₹277M₹247M
Total debt₹2.50B₹2.50B₹0₹0₹0

Quarterly statements and history in the cockpit →

Canara HSBC Life Insurance competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-20%-10%0%NIVABUPANBG60856200376088350CLOVBHF71575859002423PRVASTARHEALTH2905ELFCANHLIFE.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Canara HSBC Life Insurance is the large dot.

Fundamentals: return on equity against price-to-book

-100%-50%0%00×2.50×50×7.50×NIVABUPANBG60856200376088350CLOVBHFPRVASTARHEALTH2905CANHLIFE.NSReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Canara HSBC Life Insurance is the large dot.

Capital: ROE delivered against the ROE the price implies

-100%-50%0%50%-100%0%NIVABUPANBG6085620CLOVSTARHEALTH2905CANHLIFE.NSROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Canara HSBC Life Insurance is the large dot.

Canara HSBC Life Insurance competitors and peer comparison

Head to head with its named competitors (CANHLIFE.NS vs HDFCLIFE.NS vs SBILIFE.NS vs NIVABUPA.NS)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Canara HSBC Life Insurance CANHLIFE.NS$1.29B-8%+17%8%7.36×50.5%
HDFC Life Insurance HDFCLIFE.NS$13.3B-6%+19%11%6.42×73.8%
SBI Life Insurance SBILIFE.NS$19.2B-5%+18%14%8.74×106.5%
Niva Bupa Health Insurance NIVABUPA.NS$1.46B-9%+58%14%3.55×32.5%

How Canara HSBC Life Insurance compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Canara HSBC Life Insurance against its 14 peers (data as of 18 Nov 2026)
MeasureCANHLIFE.NSPeer medianRank in peer set
1-month return-0.9%-2.8%7th highest of 15
6-month return-7.8%+0.7%6th lowest of 15
Return on equity8.2%6.2%5th highest of 15
Price / book7.36×0.95×most expensive of 15
Trailing P/E37.6×15.5×4th most expensive of 14
ROE the price implies50.5%6.3%2nd most demanding of 15
ROE delivered8.2%6.2%5th highest of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Canara HSBC Life Insurance CANHLIFE.NSIndia$1.29B-8%+17%8%7.36×50.5%8.2%
Niva Bupa Health Insurance NIVABUPA.NSIndia$1.46B-9%+58%14%3.55×32.5%13.9%
Nuernberger Beteiligungs NBG6.DEGermany$1.55B+2%-1%5%1.58×6.1%5.1%
Mirae Asset Life Insurance 085620.KSSouth Korea$1.70B+19%+152%2%1.06×5.8%1.8%
Yunfeng Financial 0376.HKHong Kong$872M-24%+21%7%0.53×7.4%6.7%
Hanwha Life 088350.KSSouth Korea$2.09B-33%+20%5%0.23×3.8%4.6%
Clover Health Investments CLOVUnited States$2.21B+16%+54%3%5.31×81.1%3.4%
Brighthouse Financial BHFUnited States$2.42B-33%-9%12%0.48×6.0%12.0%
Lifenet Insurance 7157.TJapan$652M-28%+11%8%1.11×7.0%7.6%
Farglory Life Insurance 5859.TWOTaiwan$614M-1%-48%7%0.22×1.7%7.1%
COFCO Capital 002423.SZChina$3.08B-7%-31%6%0.83×6.1%5.6%
Privia Health PRVAUnited States$3.14B+6%+19%5%3.85×25.7%4.6%
Star Health & Allied Insurance STARHEALTH.NSIndia$3.53B+8%+21%12%3.16×47.6%11.7%
Mercuries & Associates 2905.TWTaiwan$456M+11%-43%-118%0.56×2.7%-117.8%
E-L Financial ELF.TOCanada$4.65B+15%+32%20%0.69×6.5%20.2%

Questions

Who are Canara HSBC Life Insurance's main competitors?
Named competitors: HDFC Life Insurance (HDFCLIFE.NS), SBI Life Insurance (SBILIFE.NS), Niva Bupa Health Insurance (NIVABUPA.NS). The cockpit's measured peer set (industry) also includes Niva Bupa Health Insurance (NIVABUPA.NS), Nuernberger Beteiligungs (NBG6.DE), Mirae Asset Life Insurance (085620.KS), Yunfeng Financial (0376.HK), Hanwha Life (088350.KS), Clover Health Investments (CLOV).
Is Canara HSBC Life Insurance expensive compared with its peers?
On price / book it trades at 7.36× against a peer median of 0.95×, most expensive of 15 in its peer set. The share price implies a return on equity of about 50.5%; Canara HSBC Life Insurance delivers 8.2%, so the price asks more than the business earns today.
How has Canara HSBC Life Insurance stock performed?
Over six months to 18 Nov 2026 the shares returned -7.8% against +0.7% for the median peer; over one year +4.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.